The notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development

Blood

Volumn 118, Issue 7, 2011, Pages 1989-1997

  Niessen, Kyle ^a   Zhang, Gu ^a   Ridgway, John Brady ^a   Chen, Hao ^a   Kolumam, Ganesh ^a   Siebel, Christian W ^a   Yan, Minhong ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D11 4 LIGAND; EPHRIN B2; LIGAND; NEUTRALIZING ANTIBODY; NOTCH1 RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DILATATION; ENDOTHELIUM CELL; FEMALE; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 80051877458     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-319129     Document Type: Article

References (44)

1. Alitalo K., Tammela T., Petrova T.V. Lymphangiogenesis in development and human disease. Nature. 2005;438(7070):946-953. (Pubitemid 43093960)
2. François M., Caprini A., Hosking B., et al. Sox18 induces development of the lymphatic vasculature in mice. Nature. 2008;456(7222):643- 647.
3. Wigle J.T., Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98(6):769-778. (Pubitemid 29446894)
4. Oliver G., Alitalo K. The lymphatic vasculature: Recent progress and paradigms. Annu Rev Cell Dev Biol. 2005;21:457-483. (Pubitemid 41740643)
5. Karkkainen M.J., Haiko P., Sainio K., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5(1):74-80. (Pubitemid 38081471)
6. Cao R., Bjorndahl M.A., Gallego M.I., et al. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood. 2006;107(9):3531-3536.
7. Cao R., Bjorndahl M.A., Religa P., et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell. 2004;6(4):333-345. (Pubitemid 39361435)
8. Gale N.W., Thurston G., Hackett S.F., et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell. 2002;3(3):411-423.
9. Adams R.H., Wilkinson G.A., Weiss C., et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999;13(3):295-306. (Pubitemid 29095801)
10. Mäkinen T., Adams R.H., Bailey J., et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 2005;19(3):397-410. (Pubitemid 40189302)
11. Niessen K., Zhang G., Ridgway J.B., Chen H., Yan M. ALK1 signaling regulates early postnatal lymphatic vessel development. Blood. 2010;115(8):1654-1661.
12. Urness L.D., Sorensen L.K., Li D.Y. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet. 2000;26(3):328-331.
13. Seki T., Yun J., Oh S.P. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res. 2003;93(7):682-689. (Pubitemid 37222165)
14. Benedito R., Duarte A. Expression of Dll4 during mouse embryogenesis suggests multiple developmental roles. Gene Expr Patterns. 2005;5(6):750-755. (Pubitemid 40945859)
15. Benedito R., Roca C., Sorensen I., et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell. 2009;137(6):1124-1135.
16. Hellström M., Phng L.K., Hofmann J.J., et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature. 2007;445(7129):776-780. (Pubitemid 46279716)
17. Lobov I.B., Renard R.A., Papadopoulos N., et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A. 2007;104(9):3219-3224. (Pubitemid 46364140)
18. Ridgway J., Zhang G., Wu Y., et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature. 2006;444(7122):1083-1087. (Pubitemid 46018529)
19. Gridley T. Notch signaling in vascular development and physiology. Development. 2007;134(15):2709-2718. (Pubitemid 47305050)
20. Phng L.K., Gerhardt H. Angiogenesis: A team effort coordinated by notch. Dev Cell. 2009;16(2):196-208.
21. Roca C., Adams R.H. Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 2007;21(20):2511-2524. (Pubitemid 47607663)
22. Shawber C.J., Funahashi Y., Francisco E., et al. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin Invest. 2007;117(11):3369-3382. (Pubitemid 350096993)
23. Geudens I., Herpers R., Hermans K., et al. Role of delta-like-4/Notch in the formation and wiring of the lymphatic network in zebrafish. Arterioscler Thromb Vasc Biol. 2010;30(9):1695-1702.
24. Shawber C.J., Kitajewski J. Arterial regulators taken up by lymphatics. Lymphat Res Biol. 2008;6(3-4):139-143.
25. Kang J., Yoo J., Lee S., et al. An exquisite crosscontrol mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells. Blood. 2010;116(1):140-150.
26. Krebs L.T., Shutter J.R., Tanigaki K., Honjo T., Stark K.L., Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 2004;18(20):2469-2473. (Pubitemid 39362888)
27. Swiatek P.J., Lindsell C.E., Del Amo F.F., Weinmaster G., Gridley T. Notch1 is essential for postimplantation development in mice. Genes Dev. 1994;8(6):707-719. (Pubitemid 24116765)
28. Wu Y., Cain-Hom C., Choy L., et al. Therapeutic antibody targeting of individual Notch receptors. Nature. 2010;464(7291):1052-1057.
29. Liang W.C., Wu X., Peale F.V., et al. Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J Biol Chem. 2006;281(2):951-961.
30. Joukov V., Kumar V., Sorsa T., et al. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem. 1998;273(12):6599-6602. (Pubitemid 28160314)
31. Mäkinen T., Jussila L., Veikkola T., et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7(2):199-205. (Pubitemid 32148487)
32. Wang Y., Nakayama M., Pitulescu M.E., et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature. 2010;465(7297):483-486.
33. Iso T., Maeno T., Oike Y., et al. Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells. Biochem Biophys Res Commun. 2006;341(3):708-714. (Pubitemid 43177547)
34. Lawson N.D., Scheer N., Pham V.N., et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development. 2001;128(19):3675-3683. (Pubitemid 32998917)
35. Carlson T.R., Yan Y., Wu X., et al. Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci U S A. 2005;102(28):9884-9889. (Pubitemid 40993662)
36. Herbert S.P., Huisken J., Kim T.N., et al. Arterialvenous segregation by selective cell sprouting: An alternative mode of blood vessel formation. Science 2009;326(5950):294-298.
37. Hainaud P., Contreres J.O., Villemain A., et al. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Cancer Res. 2006;66(17):8501-8510. (Pubitemid 44449163)
38. Chigurupati S., Arumugam T.V., Son T.G., et al. Involvement of notch signaling in wound healing. PloS ONE. 2007;2(11):e1167.
39. Outtz H.H., Wu J.K., Wang X., Kitajewski J. Notch1 deficiency results in decreased inflammation during wound healing and regulates vascular endothelial growth factor receptor-1 and inflammatory cytokine expression in macrophages. J Immunol. 2010;185(7):4363-4373.
40. You L.R., Lin F.J., Lee C.T., DeMayo F.J., Tsai M.J., Tsai S.Y. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature. 2005;435(7038):98-104. (Pubitemid 40655915)
41. Gupta G.P., Massague J. Cancer metastasis: Building a framework. Cell. 2006;127(4):679-695. (Pubitemid 44781029)
42. Noguera-Troise I., Daly C., Papadopoulos N.J., et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 2006;444(7122):1032-1037. (Pubitemid 46018516)
43. Scehnet J.S., Jiang W., Kumar S.R., et al. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007;109(11):4753-4760. (Pubitemid 46827768)
44. Yan M., Plowman G.D. Delta-like 4/Notch signaling and its therapeutic implications. Clin Cancer Res. 2007;13(24):7243-7246.